An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Europe B.V.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
All male patients \> 18 years of age with advanced PCa to whom oncourologist decided to prescribe Eligard 45 mg
You may not be if
Patient participation in any clinical trials.
Clareo Health | An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
